IGF::OT::IGF: NASCare: A Mobile Tool for Diagnosis and Treatment of Neonatal Abstinence Syndrome. September 1, 2016 - March 3, 2017. N43DA-16-1211.

SBIR主题158解决了提高对新生儿戒断综合征（NAS）管理最佳实践的认识和知识的需求。这种需要是由临床严格性引起的，并引起了新生儿和儿科医生对各种戒断症状和治疗方法的关注。该合同的最终目标是开发一种技能构建入门和参考工具，以帮助临床医生识别、解释、评分和应对NAS症状，以改善新生儿结局。

SBIR Topic 158 addresses the demand to promote awareness and knowledge of the best practice in management of Neonatal Abstinence Syndrome (NAS). The need is caused by clinical rigor and raised concerns among neonatal and pediatric practitioners regarding a constellation of various withdrawal symptoms and treatment approaches. The ultimate goal of this contract is to develop a skill-building Primer and Reference Tool to assist clinicians in identifying, interpretation, scoring and responding to NAS symptoms toward improving neonatal outcomes.